Physician profile
Stephen G Opsasnick
NPI 1326015322
$334.74
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $30.58 · 2023: $89.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $88.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.08 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.78 | 2021 | |
| Exact Sciences Corporation | $27.11 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $24.79 | 2021 | |
| Glaxosmithkline, LLC. | $22.53 | 2023 | Trelegy Ellipta |
| Amgen INC. | $17.72 | 2022 | |
| Merck Sharp & Dohme LLC | $17.04 | 2021 | |
| Novo Nordisk INC | $16.04 | 2023 | Rybelsus, Ozempic |
| Abbvie INC. | $13.26 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.19 | 2023 | Eliquis |
| Lilly USA, LLC | $12.79 | 2021 | |
| Corium, LLC | $10.86 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Opsasnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.